Skip to main content
. 2022 Aug 31;19(17):10850. doi: 10.3390/ijerph191710850

Table 1.

The participants’ characteristics by SBS symptoms.

Characteristics Total
(N = 261)
Nasal Symptoms
(n = 66)
Throat Symptoms
(n = 38)
Lower Respiratory Tract Symptoms
(n = 28)
Dermal Symptoms
(n = 50)
n (%) n (%) n (%) n (%) n (%)
Age (year), mean ± SD 40 ± 11 38 ± 10 40 ± 12 37 ± 11 38 ± 10
Gender
Male 107 (41.0) 17 (25.8) 13 (34.2) 8 (28.6) 14 (28.6)
Female 154 (59.0) 49 (74.2) 25 (65.8) 20 (71.4) 35 (71.4)
Working year, median (IQR) 9 (2–20) 9 (3–15) 7 (2–17) 5 (3–15) 9 (3–14)
Smoking
Non-smoker 225 (86.2) 61 (92.4) 34 (89.5) 26 (92.9) 45 (91.9)
Ex-smoker 24 (9.2) 3 (4.6) 3 (7.9) 2 (7.1) 3 (6.1)
Current-smoker 12 (4.6) 2 (3.0) 1 (2.6) - 1 (2.0)
Underlying disease
None 165 (63.2) 38 (57.6) 20 (52.6) 11 (39.3) 26 (53.1)
Allergic rhinitis 31 (11.9) 13 (19.7) 8 (21.1) 8 (28.6) 7 (14.3)
Sinusitis 2 (0.8) 2 (3.0) 2 (5.41) - 1 (2.0)
Asthma 1 (0.4) 1 (1.5) 1 (2.7) - 1 (2.0)
Skin diseases 5 (1.9) 2 (3.0) 1 (2.6) 1 (3.6) 3 (6.1)
Workers’ perception in working environments
Feeling sensitive to smoke 237 (90.8) 62 (93.9) 35 (92.1) 25 (89.3) 45 (91.8)
Feeling sensitive to chemical agents 190 (80.3) 53 (80.3) 28 (73.7) 22 (78.6) 37 (75.5)
Working conditions
Regular working hours per week,
mean ± SD
37 ± 8 40 ± 6 39 ± 4 41 ± 7 39 ± 4
Overtime working hours per week,
median (IQR)
2 (0–5) 2 (0–5) 3 (0–5) 3 (0–5) 2 (1–5)
Room sizes (m3), n (%)
≤250 89 (34.10) 26 (39.39) 10 (26.32) 10 (35.71) 16 (32.65)
251–400 60 (22.99) 17 (25.76) 12 (31.58) 6 (21.43) 14 (28.57)
401–600 34 (13.03) 5 (7.58) 6 (15.79) 4 (14.29) 5 (10.20)
601–1000 63 (24.14) 16 (24.24) 8 (21.05) 7 (25.00) 13 (26.53)
≥1000 15 (5.75) 2 (3.03) 2 (5.26) 1 (3.57) 1 (2.04)
Number of workers per room (IQR) 19 (10–28) 18 (10–28) 18 (12–28) 18 (10–29) 18 (10–31)